Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Neurology·2026
Same author

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Evaluation of the yield index of genetic counselling for first-degree relatives of patients with hereditary transthyretin cardiac amyloidosis.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2026
Same author

External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database.

Multiple sclerosis and related disorders·2026
Same author

Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

Neurology·2026
Same author

Adult case of 17β-hydroxysteroid dehydrogenase type 10 (HSD10) deficiency due to the p. Arg130Cys mutation of the <i>HSD17B10</i> gene: case report.

AME case reports·2026

Related Experiment Video

Updated: Apr 30, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.1K

A reversible functional sensory neuropathy model.

Aurore Danigo1, Laurent Magy2, Laurence Richard2

  • 1EA 6309 - Schools of Medicine and Pharmacy - University of Limoges, France.

Neuroscience Letters
|May 6, 2014
PubMed
Summary

Resiniferatoxin (RTX) causes temporary depletion of neuropeptides in sensory neurons without nerve damage in mice. This model is valuable for studying early-stage small fiber neuropathy and potential therapeutic strategies.

Keywords:
Calcitonin-gene related peptideIntraepidermal nerve fiberNociceptionResiniferatoxinSmall-fiber neuropathySubstance P

More Related Videos

Novel Surgical Rodent Model for Studying Neuroma Pain Treatment Options using Targeted Muscle Reinnervation Through the Saphenous Nerve
07:00

Novel Surgical Rodent Model for Studying Neuroma Pain Treatment Options using Targeted Muscle Reinnervation Through the Saphenous Nerve

Published on: November 14, 2025

271
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

7.6K

Related Experiment Videos

Last Updated: Apr 30, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.1K
Novel Surgical Rodent Model for Studying Neuroma Pain Treatment Options using Targeted Muscle Reinnervation Through the Saphenous Nerve
07:00

Novel Surgical Rodent Model for Studying Neuroma Pain Treatment Options using Targeted Muscle Reinnervation Through the Saphenous Nerve

Published on: November 14, 2025

271
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

7.6K

Area of Science:

  • Neuroscience
  • Pain Research
  • Pharmacology

Background:

  • Small-fiber neuropathy (SFN) affects unmyelinated nerve fibers, leading to sensory deficits.
  • Current models often involve nerve degeneration, limiting the study of early functional changes.
  • Resiniferatoxin (RTX), a TRPV1 agonist, offers a potential method to induce SFN without overt nerve damage.

Purpose of the Study:

  • To investigate the effects of RTX-induced small-fiber neuropathy in mice.
  • To characterize the temporal changes in neuropeptide expression and sensory function.
  • To evaluate the utility of this model for studying early SFN and therapeutic interventions.

Main Methods:

  • Small-fiber neuropathy was induced in mice via intraperitoneal injection of RTX.
  • Thermal and mechanical nociception were assessed at days 7 and 28 post-injection.
  • Neuropeptide levels (Substance P and CGRP) in dorsal root ganglia (DRG) and intraepidermal nerve fibers (IENFs) were analyzed.

Main Results:

  • RTX induced significant thermal and mechanical hypoalgesia by day 7, which resolved by day 28.
  • No significant nerve degeneration was observed in skin or sciatic nerves.
  • Substance P (SP) and Calcitonin Gene-Related Peptide (CGRP) were depleted in DRG neurons at day 7, with restoration by 3 weeks.
  • CGRP remained low in IENFs, while SP expression improved.

Conclusions:

  • RTX induces a transient neuropeptide depletion in sensory neurons without causing nerve degeneration.
  • This RTX-induced model is valuable for studying the early functional changes in small fiber neuropathy.
  • The model serves as a useful tool for investigating therapeutic strategies against sensory neuropathy.